Vir Biotechnology Inc (VIR)
Healthcare
Biotechnology
8.70 $
-2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Vir Biotechnology Inc (VIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -392 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -66 | -94 | -130 | -191 | -48 | 1,663 | -779 | -446 | -392 | |
| 0.4 | 2.8 | 4.5 | 5.4 | 5.8 | 6.8 | 19 | 15 | 21 | |
| 4.8 | 5.1 | 8.7 | 28 | 84 | 102 | 111 | 78 | 49 | |
| -1.8 | 6.5 | 32 | 45 | 46 | 475 | – | – | – | |
| 4.9 | 12 | 8.2 | 30 | -628 | 665 | -305 | -84 | -22 | |
| 2.7 | 8.2 | 8.9 | 6.5 | 22 | 68 | 22 | 7.3 | 4.8 | |
| -30 | -60 | -256 | -9.9 | -141 | -1,193 | 165 | 499 | 310 | |
| 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 0.0 | 15 | 0.0 | 327 | 15 | 3.2 | – | – | – | |
| 1.1 | 1.1 | 1.1 | -0.3 | -0.3 | -0.3 | -0.3 | – | – | |
| 271 | 25 | 449 | 529 | 100 | 35 | 7.4 | 4.4 | 3.8 | |
| 175 | -130 | 63 | 329 | -88 | 505 | -606 | 57 | -78 | |
| -69 | -102 | -139 | -197 | -69 | 1,595 | -800 | -454 | -397 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.